$12.51 +0.16 (1.30%)

Crescent Biopharma, Inc. Common Stock (CBIO)

🚫 Crescent Biopharma, Inc. Common Stock does not pay dividends

Company News

Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock Split
GlobeNewswire Inc. • Catalyst Biosciences, Inc. • October 30, 2023

The combined company will operate as “Gyre Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “GYRE” effective Tuesday, October 31, 2023

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Lisa Levin • October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million share...

Merck (MRK) Gets FDA Fast Track Tag for Anticoagulant Therapy
Zacks Investment Research • Zacks Equity Research • August 24, 2022

A phase II study is ongoing on Merck's (MRK) MK-2060 in people with end-stage renal disease receiving hemodialysis.

5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
PennyStocks • J. Samuel • June 17, 2022

Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: The Week Ahead (Podcast)
Seeking Alpha • Wall Street Breakfast • July 18, 2021

Earnings season heats up in a big way next week with IBM, Netflix, Chipotle, Coca-Cola and Twitter just a few of the major companies due to spill numbers.